Dec 9 (Reuters) - CVS Health (CVS) on Tuesday forecast 2026 profit above Wall Street estimates and this year's projected earnings, signalling steady progress in the health conglomerate's turnaround plan.
CVS stock rose 5% in early trading on Tuesday.
The company in October projected double-digit earnings growth for 2026 after raising its 2025 profit forecast for the third time.
"We are closing out 2025 with meaningful momentum across our businesses and we expect another year of strong earnings growth in 2026," said Chief Financial Officer Brian Newman on Tuesday.
The company forecast 2026 adjusted profit to be in the range of $7.00 to $7.20 per share, compared with analysts' average estimate of $7.16, according to data compiled by LSEG.
It, however, expects total revenue of at least $400 billion next year, below analysts' average estimate of $419.26 billion.
CVS also raised its 2025 adjusted profit forecast to $6.60 to $6.70 per share from $6.55 to $6.65 previously.
(Reporting by Sneha S K in Bengaluru; Editing by Shinjini Ganguli)
LATEST POSTS
- 1
RFK Jr. says he's following 'gold standard' science. Here's what to know - 2Top 20 Style Brands for Pioneers
- 3Flu cases are spiking earlier than usual. What you need to know.
- 4Improving as a Pioneer: Examples from My Vocation
- 5Step by step instructions to Remain Spurred While Chasing after a Web-based Degree
- 5 Home Improvement Styles: Decision in favor of Your #1
- CDC clarifies stance on vaccines and autism, stating no evidence supports the link
- 7 Fun Plans to Make Film Evenings Seriously Invigorating (You'll Cherish #5!)
- No red, no long shorts: The fashion rules Joe Burrows lives by
- Russia downs 16 drones heading for Moscow, mayor says
- Understanding Successful Compromise Standards to Cultivate Agreeable Connections
- Becoming the best at Discussion: Individual Procedures
- The most effective method to Connect Successfully with Teachers in a Web based Setting
- Hamas delegation meets Egypt’s spy chief amid mutual ceasefire violation claims
